An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With ALS
Clinical trial NCT06454682 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06454682
- Sponsor
- RJK Biopharma Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2025-06-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.